Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, June 3, 2021
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
[ Thu, Jun 03rd 2021
] - WOPRAI
Matthew Sykes Initiated (CDNA) at Strong Buy and Held Target at $95 on, Jun 3rd, 2021
Matthew Sykes of Goldman Sachs, Initiated "CareDx, Inc" (CDNA) at Strong Buy and Held Target at $95 on, Jun 3rd, 2021.
Matthew has made no other calls on CDNA in the last 4 months.
There is 1 other peer that has a rating on CDNA. Out of the 1 peers that are also analyzing CDNA, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Andrew Cooper of "Raymond James" Maintained at Strong Buy with Decreased Target to $90 on, Thursday, May 6th, 2021
